National Survey on Infiltrative Breast Cancer

AstraZeneca1,500 enrolled

Overview

The purpose of this observational study is to describe radiological, clinical and histological characteristics of women with infiltrative breast cancer.

Study Type

OBSERVATIONAL

Enrollment

1,500

Conditions

Infiltrative Breast Cancer

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Women\> or = 18 years old * Women with newly diagnosis of infiltrative breast cancer * Agree to take part in this study Exclusion Criteria: * Women with other malignant tumor (except in situ cervical carcinoma or treated basal cell carcinoma) * Women with in situ ductal carcinoma or in situ lobular carcinoma

Locations (107)

Outcomes

Primary Outcomes

Radiological, Clinical and Histological characteristics

Time frame: Once

Secondary Outcomes

Treatments: Surgery, radiotherapy, chemotherapy, hormonotherapy.

Time frame: Once

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Research Site

Aix-en-Provence, France

Research Site

Alès, France

Research Site

Amilly, France

Research Site

Angers, France

Research Site

Annecy, France

Research Site

Arpajon, France

Research Site

Arras, France

Research Site

Aubervilliers, France

Research Site

Aulnay-sous-Bois, France

Research Site

Auxerre, France

...and 97 more locations